These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16450452)

  • 1. By the way, doctor. I developed acute urinary retention after having a pacemaker put in. I'm a 90-year-old man and in pretty good shape considering my age, but I'd rather not have any more procedures. What are my options?
    O'Leary MP
    Harv Health Lett; 2006 Jan; 31(3):8. PubMed ID: 16450452
    [No Abstract]   [Full Text] [Related]  

  • 2. A large retrospective analysis of acute urinary retention and prostate-related surgery in BPH patients treated with 5-alpha reductase inhibitors: dutasteride versus finasteride.
    Issa MM; Runken MC; Grogg AL; Shah MB
    Am J Manag Care; 2007 Feb; 13 Suppl 1():S10-6. PubMed ID: 17295600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dutasteride vs finasteride: assessment of differences in acute urinary retention rates and surgical risk outcomes in an elderly population aged > or =65 years.
    Fenter TC; Davis EA; Shah MB; Lin PJ
    Am J Manag Care; 2008 May; 14(5 Suppl 2):S154-9. PubMed ID: 18611089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Alpha reductase inhibitors in men with an enlarged prostate: an evaluation of outcomes and therapeutic alternatives.
    Naslund M; Regan TS; Ong C; Hogue SL
    Am J Manag Care; 2008 May; 14(5 Suppl 2):S148-53. PubMed ID: 18611088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride.
    Kaplan SA; Chung DE; Lee RK; Scofield S; Te AE
    Int J Clin Pract; 2012 Nov; 66(11):1052-5. PubMed ID: 23067029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term cost analysis of treatment options for benign prostatic hyperplasia in Norway.
    Johansen TE; Istad JA
    Scand J Urol Nephrol; 2007; 41(2):124-31. PubMed ID: 17454951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood loss and postoperative complications associated with transurethral resection of the prostate after pretreatment with dutasteride.
    Hahn RG; Fagerström T; Tammela TL; Van Vierssen Trip O; Beisland HO; Duggan A; Morrill B
    BJU Int; 2007 Mar; 99(3):587-94. PubMed ID: 17407516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finasteride versus dutasteride: a real-world economic evaluation.
    Fenter TC; Runken MC; Black L; Eaddy M
    Am J Manag Care; 2007 Feb; 13 Suppl 1():S23-8. PubMed ID: 17295602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.
    Roehrborn CG; Nickel JC; Andriole GL; Gagnier RP; Black L; Wilson TH; Rittmaster RS
    Urology; 2011 Sep; 78(3):641-6. PubMed ID: 21764428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effects and economical impact of dutasteride and finasteride therapy in Italian men with LUTS.
    Cindolo L; Berardinelli F; Fanizza C; Romero M; Pirozzi L; Tamburro FR; Pellegrini F; Neri F; Pitrelli A; Schips L
    Arch Ital Urol Androl; 2013 Dec; 85(4):200-6. PubMed ID: 24399122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. I had surgery in 2005 to treat my enlarged prostate. The procedure was transurethral resection of the prostate. Things have worked out pretty well, but I'm wondering how long I can expect the improvement in urine flow to last?
    Mayo Clin Health Lett; 2007 Mar; 25(3):8. PubMed ID: 17402156
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of one month treatment with dutasteride on transurethral resection of the prostate].
    Arratia-Maqueo JA; Garza-Cortés R; Gómez-Guerra LS; Cortés-González JR
    Actas Urol Esp; 2010 Nov; 34(10):866-9. PubMed ID: 21159282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. I'm a 57-year-old man with high blood pressure and high cholesterol. I had a hard time regulating my pressure until I went on Vasotec, which was great. But I developed a cough, so my doctor switched me to Cozaar. My cough stopped and my pressure seems okay, but I'd like to know what you think of the switch.
    Harv Mens Health Watch; 1998 May; 2(10):8. PubMed ID: 9577264
    [No Abstract]   [Full Text] [Related]  

  • 14. Finasteride to evaluate the efficacy of dutasteride in the management of patients with lower urinary tract symptoms and enlarged prostate.
    Ravish IR; Nerli RB; Amarkhed SS
    Arch Androl; 2007; 53(1):17-20. PubMed ID: 17364459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS).
    Nickel JC; Gilling P; Tammela TL; Morrill B; Wilson TH; Rittmaster RS
    BJU Int; 2011 Aug; 108(3):388-94. PubMed ID: 21631695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. By the way, doctor. I'm one year into menopause and really bothered by hot flashes and vaginal dryness. I'd like to take hormone replacement therapy, but I'm worried about increasing my risk of getting breast cancer. My doctor said I can take HRT at a dose longer than what's usually prescribed. What do you think?
    Robb-Nicholson C
    Harv Womens Health Watch; 2001 Sep; 9(1):7. PubMed ID: 11572838
    [No Abstract]   [Full Text] [Related]  

  • 17. On call. I'm a 63-year-old man with arthritis but no other conditions. My only medicines were Naprosyn and vitamins until my last annual checkup, when my cholesterol was high. My doctor gave me Zocor, which helped. But I developed muscle aches, so he switched me to Zetia. I feel fine again, but I'd like to know what you think.
    Simon HB
    Harv Mens Health Watch; 2004 Apr; 8(9):8. PubMed ID: 15100066
    [No Abstract]   [Full Text] [Related]  

  • 18. Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study.
    Kotsar A; Isotalo T; Juuti H; Mikkonen J; Leppiniemi J; Hänninen V; Kellomäki M; Talja M; Tammela TL
    BJU Int; 2009 Mar; 103(5):626-9. PubMed ID: 18990149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study.
    Roehrborn CG; Siami P; Barkin J; Damião R; Major-Walker K; Nandy I; Morrill BB; Gagnier RP; Montorsi F;
    Eur Urol; 2010 Jan; 57(1):123-31. PubMed ID: 19825505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term pretreatment with a dual 5α-reductase inhibitor before bipolar transurethral resection of the prostate (B-TURP): evaluation of prostate vascularity and decreased surgical blood loss in large prostates.
    Busetto GM; Giovannone R; Antonini G; Rossi A; Del Giudice F; Tricarico S; Ragonesi G; Gentile V; De Berardinis E
    BJU Int; 2015 Jul; 116(1):117-23. PubMed ID: 25291499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.